Poseida Therapeutics (Roche)
Company
AcquiredAcquired by Roche in January 2025
January 2025
What they built
Non-viral gene editing platform for allogeneic CAR-T and gene therapies. Acquired by Roche in early 2025; continues operations as Roche subsidiary. San Diego.
Lifecycle
Poseida Therapeutics (Roche) was acquired in January 2025 and no longer operates as an independent entity.